ReviewImmunity, inflammation and disease2025
Nucleotide-Binding Oligomerization Domain 2 in Signaling, Immunity, and Mycobacterial Infection.
Review in Immunity, inflammation and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Liver Macrophages in the Pathogenesis of Viral Hepatitis.Current issues in molecular biology · 2026Review
- NOD2 activation reprograms infiltrating inflammatory monocytes in the Zika virus infected CNS to maintain neural correlates of learning and memory.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionNucleotide-binding oligomerization domain 2 (NOD2) functions primarily as a cytoplasmic pattern recognition receptor (PRR) that detects muramyl dipeptide (MDP), a conserved bacterial cell wall component, thereby playing a pivotal role in pathogen surveillance. However, emerging evidence reveals that NOD2 exerts broad immunomodulatory effects beyond its canonical role as a PRR, though its effects can be contradictory, depending on genetic background, immunological microenvironment, and disease context. In this review, we integrate recent advances in understanding NOD2's functional plasticity and provide novel insights into its regulatory mechanisms in immune responses and mycobacterial infections.
methodsA literature search was conducted using the PubMed database with keywords including NOD2, signaling pathways, immune homeostasis, autophagy, trained immunity, and mycobacterial infection. Relevant information was extracted from the retrieved research articles and reviews and summarized.
resultsWe delineated the MDP-dependent and -independent mechanisms of NOD2 activation and their downstream signaling cascades. We also elaborated on the classical immune responses orchestrated by NOD2, and its remarkably multifaceted noncanonical roles in regulating immune homeostasis by modulating autophagy, acting synergistically with toll-like receptor pathways to fine-tune inflammation, and balancing trained immunity and immune tolerance. Furthermore, we examined the multifaceted immunoregulatory functions of NOD2 in host defense against mycobacterial infections.
conclusionsWe propose that further research is required to clarify the various roles of NOD2 across diverse genetic backgrounds, microenvironmental contexts, and disease paradigms. Such studies will provide critical mechanistic insights to inform the development of precision-based therapeutic strategies targeting NOD2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.